Supplemental Figure 5 from High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma
Year: 2023
Type: supplementary-materials
Abstract: Anti-gp350 antibodies among Prevalent NPC, Incident NPC, and Control participants.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361884602